Patent ID: 9090570
Filing Date: 2015-07-28
Classification: A61K,A61P,C07D,Y02A

Abstract:
1. A method of treating organ transplant rejection, psoriasis, atopic dermatitis, chronic autoimmune urticaria, rheumatoid arthritis, hemolytic anemia, ulcerative colitis, Crohn's disease, or uveitis in a subject in need thereof, comprising administering to the subject an effective amount of a compound represented by structural formula (V): or a pharmaceutically acceptable salt thereof, wherein: each Z is independently selected from the group consisting of a lower alkyl, a lower haloalkyl, a halo, a lower alkoxy, a lower alkyl sulfanyl, cyano, nitro, and lower haloalkoxy; R R R R R R R X X X n is 0, 1 or 2; and p is 1 or 2.